Wuppertal, Germany

Nuria Ortega Hernandez

This inventor holds 2 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nuria Ortega Hernandez. Retrieved from https://idiyas.com/inventor/nuria-ortega-hernandez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nuria Ortega Hernandez: Innovator in Cardiovascular Medicine

Introduction

Nuria Ortega Hernandez is an accomplished inventor based in Wuppertal, Germany, with significant contributions to the field of medicinal chemistry. Her research primarily focuses on developing innovative compounds aimed at treating various cardiovascular and related diseases. With a strong academic foundation and a passion for improving patient outcomes, she has garnered recognition in her field.

Latest Patents

Nuria Ortega Hernandez holds a patent for "Substituted Pyrazolo Piperidine Carboxylic Acids." This invention involves the creation of substituted pyrazolo piperidine carboxylic acids and their salts, along with processes for their preparation. Moreover, it highlights their application in formulating medicaments intended for the treatment and/or prophylaxis of numerous diseases, including but not limited to cardiovascular conditions like heart failure with reduced and preserved ejection fraction, hypertension, and peripheral arterial diseases. Additionally, her work addresses a wide array of conditions, such as chronic kidney disease, pulmonary hypertension, neurodegenerative diseases, and wound healing disorders.

Career Highlights

Nuria is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company committed to advancing health and nutrition. In her capacity at Bayer, she has made significant strides in the development of innovative therapies, particularly in the domain of cardiovascular health and beyond. Her dedication to research and development reflects her commitment to scientific excellence and patient care.

Collaborations

Throughout her career, Nuria Ortega Hernandez has collaborated with talented professionals in her field. Notably, she has worked alongside colleagues such as Alexandros Vakalopoulos and Marie-Pierre Collin-Kröpeln. These collaborations have enabled her to enhance her research, merge diverse expertise, and drive forward her innovative projects.

Conclusion

Nuria Ortega Hernandez stands out as a forward-thinking inventor whose work has the potential to significantly impact the healthcare industry. Her dedication to solving complex medical challenges through innovative solutions underscores the importance of research and collaboration in achieving advancements in medicine. As she continues to pursue new avenues for innovation, Nuria's contributions to the field of cardiovascular treatment will undoubtedly benefit many patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…